All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How did newer prognostic models change treatment algorithms in primary and secondary MF?

During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, the MPN Hub spoke with Laura Michaelis, Medical College of Wisconsin, Milkwaukee, US. We asked, How did newer prognostic models change treatment algorithms in primary and secondary MF?

How did newer prognostic models change treatment algorithms in primary and secondary MF?

Michaelis discusses prognostic models in myelofibrosis such as the International Prognostic Scoring System (IPSS).

 

Share: